share_log

Bellerophon Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(0%),Janus Henderson Biotech Innovation Master Fund Ltd(0%)

Bellerophon Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(0%),Janus Henderson Biotech Innovation Master Fund Ltd(0%)

SEC announcement ·  2023/06/09 13:03
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息